Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
2.9900
+0.2800 (10.33%)
NASDAQ · Last Trade: Sep 2nd, 4:37 PM EDT
Detailed Quote
Previous Close | 2.710 |
---|---|
Open | 2.950 |
Bid | 2.900 |
Ask | 2.940 |
Day's Range | 2.770 - 3.040 |
52 Week Range | 2.530 - 33.66 |
Volume | 1,322,442 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,361,690 |
Chart
News & Press Releases
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · August 22, 2025
Via Benzinga · August 22, 2025
Via Benzinga · August 21, 2025
Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value
By Liminatus Pharma Inc. · Via GlobeNewswire · July 28, 2025
Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed
By Liminatus Pharma Inc. · Via GlobeNewswire · July 25, 2025
Via Benzinga · July 24, 2025
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths
By Liminatus Pharma Inc. · Via GlobeNewswire · July 24, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · July 24, 2025
Via Benzinga · July 24, 2025
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation
By Liminatus Pharma Inc. · Via GlobeNewswire · July 22, 2025
Via Benzinga · July 17, 2025
Via Benzinga · July 10, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 3, 2025
U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.
Via Benzinga · July 2, 2025
Via Benzinga · June 30, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 24, 2025